<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01096264</url>
  </required_header>
  <id_info>
    <org_study_id>2009-03</org_study_id>
    <nct_id>NCT01096264</nct_id>
  </id_info>
  <brief_title>Non-Invasive Quantitative Imaging of Human Local Arterial Wall Elasticity Using Supersonic Shear Imaging</brief_title>
  <acronym>ULTRAFASTECHO</acronym>
  <official_title>Establishment of Local Arterial Stiffness Normal Values (Carotid and Femoral) on Healthy Volunteers Using Supersonic Shear Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French Cardiology Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Agency, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SOCIETE FRANCAISE DE MEDECINE VASCULAIRE</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>French Cardiology Society</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Arterial stiffness is associated with increased risk of cardiovascular events and death.&#xD;
&#xD;
      Most of existing technique need dedicated device for arterial stiffness evaluation and&#xD;
      indirect calculation of intra arterial pressure. Supersonic Shear Imaging (SSI) is a novel&#xD;
      non-invasive technique based on remote palpation of biological tissues that can image with&#xD;
      very high temporal resolution (up to 10,000 images/s) and quantify the local viscoelastic&#xD;
      properties of tissues. The investigators goal was to apply this SSI technique for arterial&#xD;
      stiffness evaluation and local pulse wave velocity (PWV) calculation.&#xD;
&#xD;
      As a first step, the primary goal of this study is to establish normal values of local pulse&#xD;
      wave velocity and arterial stiffness (carotid and femoral) by SSI on hundred healthy&#xD;
      volunteers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Provide a more extensive description, if desired. Avoid duplication of information to be&#xD;
      recorded elsewhere, such as eligibility criteria or outcome measures.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Normal Values by SSI</measure>
    <time_frame>day one</time_frame>
    <description>Normal Values by SSI of local PWV and arterial wall stiffness(carotid and femoral).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>repeatability of the &quot;primary outcome measure&quot;</measure>
    <time_frame>Day one</time_frame>
    <description>Evaluation of the repeatability of the &quot;primary outcome measure&quot; on 100 healthy volunteers and 30 patients with Vascular Ehlers Danlos Syndrome (vEDS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison between 2 populations of values by SSI</measure>
    <time_frame>Day one</time_frame>
    <description>Comparison between healthy volunteers and vEDS patients for PWV and arterial stiffness evaluated by SSI.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of values between SSI and standard gold</measure>
    <time_frame>Day one</time_frame>
    <description>Concordance evaluation between PWV calculated by SSI and Aortic Pulse wave velocity calculated by ShygmoCor®</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">145</enrollment>
  <condition>Healthy Volunteers</condition>
  <condition>Vascular Ehlers Danlos Syndrome</condition>
  <arm_group>
    <arm_group_label>Healthy volunteer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Healthy volunteer undergoing two imagery evaluation :&#xD;
SSI technique for local PWV and arterial stiffness evaluation&#xD;
SphygmoCor® for aortic PWV.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vEDS patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>vEDS patients undergoing two imagery evaluations:&#xD;
SSI technique for local PWV and arterial stiffness evaluation&#xD;
SphygmoCor® for aortic PWV.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SSI and SphygmoCor® evaluations</intervention_name>
    <description>SSI evaluation need Aixplorer vascular ultrasound machine (available in our department) with 8 MHz linear array probe applied on the carotid and femoral artery.&#xD;
SphygmoCor® evaluation used pressure captors on carotid and femoral sites to record the intra-arterial pressure wave time delay after QRS wave. After distance calculation between the two sites, Aortic PWV can be derived.</description>
    <arm_group_label>Healthy volunteer</arm_group_label>
    <arm_group_label>vEDS patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria for Healthy Volunteers&#xD;
&#xD;
          -  Healthy volunteers between 18 and 70 years old of two sexes.&#xD;
&#xD;
          -  Caucasian origin&#xD;
&#xD;
          -  No tobacco or stopped for more than 5 years&#xD;
&#xD;
          -  BMI between 18 and 30 kg/m2.&#xD;
&#xD;
          -  Blood pressure after 5 minutes of rest &lt; 140 and 90 mmHg.&#xD;
&#xD;
          -  Biological test (haematological biochemistry test in blood , urine test and toxicology&#xD;
             tests are all normal) ECG, Blood pressure and Heart rhythm normal.&#xD;
&#xD;
          -  All volunteers received information on the research and signed the consent form.&#xD;
&#xD;
          -  Health system protection required&#xD;
&#xD;
        Inclusion criteria for patient :&#xD;
&#xD;
          -  Age between, 18 et 70 years old for the two sexes&#xD;
&#xD;
          -  Presence of two major criteria of Villefranche classification (Am J Med Genet 1998&#xD;
             ;77:31-7) and/or heterozygote pathogen mutation of COL3A1 gene.&#xD;
&#xD;
          -  At least 4cm long normal arterial segment (carotid or femoral) analyzed by mode B&#xD;
             echograph.&#xD;
&#xD;
          -  All patient received information on the research and signed the consent form.&#xD;
&#xD;
          -  Health system protection required&#xD;
&#xD;
        General Exclusion Criteria :&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Echograph gel allergy&#xD;
&#xD;
          -  Local Artery disease (dissection or thrombosis)&#xD;
&#xD;
          -  Arrhythmia&#xD;
&#xD;
          -  No health insurance coverage&#xD;
&#xD;
          -  Incapacity or refused to sign the consent form&#xD;
&#xD;
        Exclusion criteria for Healthy volunteers&#xD;
&#xD;
          -  Acute or Chronic Systemic disease (atherosclerosis)&#xD;
&#xD;
          -  Alcohol abuse or drug abuse (cocaine,cannabis,etc..)&#xD;
&#xD;
          -  Active or past tobacco&#xD;
&#xD;
          -  Hypercholesterolemia (LDLc &gt;1.09 g/l)&#xD;
&#xD;
          -  Exclusion period according to the national record for volunteer of clinical trial.&#xD;
&#xD;
        Exclusion criteria for Patients&#xD;
&#xD;
          -  No intact (carotid or femoral) segment for SSI analysis&#xD;
&#xD;
          -  AT2 inhibitors or Beta blockers treatment will be notified but are not considered as&#xD;
             exclusion criteria.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel Messas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anne Blanchard, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joseph Emmerich, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xavier Jeunemaitre, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Franck, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Olivier Steinchen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michel Azizi, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CIC - Hôpital Européen Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>March 19, 2010</study_first_submitted>
  <study_first_submitted_qc>March 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2010</study_first_posted>
  <last_update_submitted>March 6, 2015</last_update_submitted>
  <last_update_submitted_qc>March 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 9, 2015</last_update_posted>
  <responsible_party>
    <name_title>Dr Emmanuel Messas</name_title>
    <organization>Hôpital Européen Georges Pompidou</organization>
  </responsible_party>
  <keyword>Arterial stiffness</keyword>
  <keyword>Pulse wave velocity</keyword>
  <keyword>Ultrafastecho</keyword>
  <keyword>Supersonic shear imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ehlers-Danlos Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

